Nationally Notifiable Infectious Diseases and Conditions, United States: Weekly Tables

Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending July 27, 2024 (Week 30)
Reporting Area Chlamydia trachomatis infection §
Current weekPrevious 52 weeks Max †Cum YTD 2024 †Cum YTD 2023 †
U.S. Residents, excluding U.S. Territories 14,168 35,182 774,116 959,760
New England 69 1,102 19,827 30,859
Connecticut - 269 - 7,295
Maine 43 81 1,507 1,691
Massachusetts - 647 14,049 16,595
New Hampshire - 76 1,261 1,620
Rhode Island - 389 2,264 2,854
Vermont 26 33 746 804
Middle Atlantic 2,851 4,379 105,090 114,771
New Jersey 441 788 17,629 20,665
New York (excluding New York City) 882 957 22,351 24,055
New York City 777 1,565 35,390 38,463
Pennsylvania 751 1,168 29,720 31,588
East North Central 1,702 4,704 92,154 131,897
Illinois 32 1,497 17,009 40,665
Indiana 392 720 17,388 20,049
Michigan 183 1,020 16,275 24,443
Ohio 646 1,153 28,156 32,280
Wisconsin 449 533 13,326 14,460
West North Central 474 2,118 49,908 56,137
Iowa 143 313 6,718 7,978
Kansas 98 304 6,788 7,796
Minnesota 88 486 11,141 12,657
Missouri - 724 16,498 17,652
Nebraska 87 246 4,692 5,208
North Dakota 49 87 1,747 1,987
South Dakota 9 118 2,324 2,859
South Atlantic 3,362 12,279 195,412 220,693
Delaware 104 227 3,031 3,254
District of Columbia 17 191 3,728 4,936
Florida 1,596 6,935 63,125 65,091
Georgia 218 1,534 37,309 42,813
Maryland 1 1,016 16,375 20,389
North Carolina 8 1,434 28,898 38,557
South Carolina 705 820 18,911 19,163
Virginia 713 934 21,764 24,003
West Virginia - 115 2,271 2,487
East South Central 1,164 2,748 34,607 62,998
Alabama 649 895 18,492 19,718
Kentucky 413 592 9,049 9,260
Mississippi 102 1,006 7,066 11,869
Tennessee - 1,313 - 22,151
West South Central 765 4,788 104,033 131,548
Arkansas 192 394 9,176 10,670
Louisiana 399 799 18,832 21,175
Oklahoma 58 424 5,776 11,480
Texas 116 3,280 70,249 88,223
Mountain 952 2,691 56,367 66,702
Arizona 447 929 21,602 23,512
Colorado - 857 12,903 14,692
Idaho 77 145 2,937 3,380
Montana 40 98 1,865 2,089
Nevada 190 357 6,345 9,027
New Mexico 21 256 4,163 6,520
Utah 153 255 5,732 6,409
Wyoming 24 52 820 1,073
Pacific 2,829 5,124 116,718 144,155
Alaska 76 125 2,800 3,003
California 2,147 3,947 95,969 112,278
Hawaii - 146 - 3,675
Oregon 261 382 7,985 8,762
Washington 345 609 9,964 16,437
U.S. Territories - 135 667 2,952
American Samoa - 0 - -
Commonwealth of Northern Mariana Islands - 0 - -
Guam - 0 - -
Puerto Rico - 135 667 2,952
U.S. Virgin Islands - 0 - -
Non-U.S. Residents 1 3 16 33
Total 14,169 35,226 774,799 962,745
  • U: Unavailable — The reporting jurisdiction was unable to send the data to CDC or CDC was unable to process the data.
  • -: No reported cases — The reporting jurisdiction did not submit any cases to CDC.
  • N: Not reportable — The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction.
  • NN: Not nationally notifiable — This condition was not designated as being nationally notifiable.
  • NP: Nationally notifiable but not published.
  • NC: Not calculated — There is insufficient data available to support the calculation of this statistic.
  • Cum: Cumulative year-to-date counts.
  • * Case counts for reporting years 2023 and 2024 are provisional and subject to change. Cases are assigned to the reporting jurisdiction submitting the case to NNDSS, if the case's country of usual residence is the U.S., a U.S. territory, unknown, or null (i.e. country not reported); otherwise, the case is assigned to the 'Non-U.S. Residents' category. Country of usual residence is currently not reported by all jurisdictions or for all conditions. For further information on interpretation of these data, see https://www.cdc.gov/nndss/data-statistics/readers-guides/.
  • † Previous 52 week maximum and cumulative YTD are determined from periods of time when the condition was reportable in the jurisdiction (i.e., may be less than 52 weeks of data or incomplete YTD data).
  • § Beginning in January 2022, only confirmed cases are published to align with the approved CSTE position statement 21-ID-06, whereas in previous years, all case classification statuses were published. This change may cause a decrease in published case counts when compared to previous years.